3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDGeographic Atrophy, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, eye disorder, macular degeneration, retinal degeneration, retinal disorderRecruitingPhase 22026-10-05NCT06659549
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMDGeographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingNot applicable2026-06-01NCT04676854
Low-dose Atropine for Myopia Control in ChildrenMyopia, Progressive, degenerative myopia, eye disorder, myopia, refractive errorActive, not recruitingPhase 2 / Phase 32025-03-06NCT03865160